| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 10/07/2004 | US20040198750 Compositions useful as inhibitors of protein kinases |
| 10/07/2004 | US20040198741 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198734 2-(4-Aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040197268 Alzheimer's disease therapy |
| 10/07/2004 | US20040194227 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibres |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | CA2520249A1 Process for preparing a polymorph of rosiglitazone maleate |
| 10/07/2004 | CA2519288A1 N-phenyl-[(4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 10/07/2004 | CA2519265A1 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463718A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 10/06/2004 | EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1080082B1 Intermediates for the synthesis of epothilones and methods for their preparation |
| 10/06/2004 | EP1032424B9 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 10/06/2004 | EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 10/06/2004 | EP0918772B1 Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1535271A Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation |
| 10/06/2004 | CN1535267A 5-membered heterocycles, preparation and use thereof as medicine |
| 10/06/2004 | CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/06/2004 | CN1535149A Topical application of thiazolyl amides |
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/06/2004 | CN1169792C Substituted vinylpyridine derivatives and drugs containing the same |
| 10/06/2004 | CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800628 Such as (1-(2-((3-methyl-2-pyrazinyl)amino)ethyl)-4-piperidinyl)-methyl-4-amino-5 -chloro-2,3-dihydro-7-benzofurancarboxylate |
| 10/05/2004 | US6800621 Imidazo[4,5-b]-pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum activity |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 09/30/2004 | WO2004083235A2 Tie-2 modulators and methods of use |
| 09/30/2004 | WO2004083218A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 09/30/2004 | WO2004082678A1 Aryl spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004082638A2 Histone deacetylase inhibitors |
| 09/30/2004 | WO2004082621A2 Novel ppar agonists, pharmaceutical compositions and uses thereof |
| 09/30/2004 | WO2004043349A3 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | US20040192926 Substituted indolyl quinolinone compounds; angiogenesis inhibitors; antitumor agents; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 09/30/2004 | US20040192767 EP4 receptor antagonists |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192753 Methods of use of thrombin receptor antagonists |
| 09/30/2004 | US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease |
| 09/30/2004 | US20040192749 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 09/30/2004 | US20040192748 Heterocyclic compounds |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192729 Purification of antibodiees; elisa; neurotransmitter research; antidiabetic agents; skin disorders; antiinflammatory agents; antihistamines |
| 09/30/2004 | US20040192712 Insecticides; for human or veterinary medicine |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192612 For treating diseases of the central nervous system, preserving organ transplant tissues or blood; treating cancer via immunotherapy; various other autoimmune, cardiovascular, and viral diseases; 1-oxo-1H-isoquinoline pro-drug esters, amides, or hydroxamides that cross the blood brain barrier |
| 09/30/2004 | US20040187225 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye |
| 09/30/2004 | CA2518843A1 Aryl spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518679A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | CA2518318A1 Histone deacetylase inhibitors |
| 09/29/2004 | EP1462451A1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof |
| 09/29/2004 | EP1462450A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461318A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 09/29/2004 | EP1114033B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 09/29/2004 | EP1019378B1 Hypoglycemic and hypolipidemic compounds |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP0928789B1 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same |
| 09/29/2004 | EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 09/29/2004 | EP0805804B1 Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides |
| 09/29/2004 | CN1533389A Azole derivatives useful as insecticide |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |